欧林生物：控股股东上海武山拟减持不超3%公司股份

Group 1 - The controlling shareholder, Shanghai Wushan Biotechnology Co., Ltd., plans to reduce its stake by up to 12.178 million shares, representing 3% of the company's total share capital [1] - The reduction will occur through centralized bidding or block trading methods [1] - The reduction period is set for three months starting 15 trading days after the announcement, with the selling price determined by market conditions [1]